PATENT CLAIM ANALYSIS

Application Number: 16313956
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["546", "197000"]

Abstract:
Compounds of formula I, wherein R a  and R b  are as defined in the claims, exhibit alpha2C antagonistic activity and are thus useful as alpha2C antagonists.

Claim (Index 17):
The pharmaceutical composition according to  claim 16  wherein the composition comprises further another active ingredient.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 98.0
- Lexical Diversity: 1.25
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12668918', '14192131', '13917745', '14747485', '14725683']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8075663082972935
- 35 USC 102 Novelty (BERT): 0.5282886045854166
- Combined Prediction Score: 0.7796385379261058
- Mean Citation Score: 313.98425400000013
- Max Citation Score: 358.68304
- Similarity Product: 277.5100959321689

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test